0
Can fibroadenomas in breast turn into breast cancer in a young age?
- 1 people answered
1 Vote
1 Contributor
2584 Views 
0 Saved
1 Vote 1 Contributor2584 Views 0 SavedYou might also be interested in
Study findings on a potential link between breast size and breast cancer have been mixed. Some studies have found having a larger breast size increases risk, while others have found no link between breast size and risk but few studies have suggested that breast size increases risk among thin women,....
The American Cancer Society recommends these cancer screening guidelines for most adults. Screening tests are used to find cancer before a person has any symptoms. Women aged 40 to 44 should have the choice to start annual breast cancer screening with mammograms (x-rays of the breast) if they wish t....
A benign tumor means it’s not cancer. These tumors don’t spread to other parts of the body and are usually not life-threatening. However, depending on their size or location, they may need to be removed if they press on important organs or cause discomfort.
Shmilona Punn
A number of masses can be found within the female breast but not all of them are cancerous. So, don’t panic if you find a mass. Among the benign masses, most are only an inconvenience and have no threat, but some may be associated with increased long-term risk of breast cancer.
A fibroadenoma is a benign mass of fibrous and glandular tissue. They are most commonly found in women aged 15 to 35. They enhance in size with estrogen stimulation and regress after the menopause.
There are two basic types of fibroadenomas: simple and complex. Simple fibroadenomas don’t pose an increased risk of breast cancer and often a surgical removal of the mass and the routine follow-up is enough.
A complex fibroadenoma can be related to a modest increase in long-term risk of breast cancer. A woman with this mass is 1.5 to 2 times more likely to have breast cancer in her lifetime than women in general. The treatment of a complex fibroadenoma is the complete surgical removal and then enhanced surveillance or enhanced screening for breast cancer.